Beyond Medical Company Top Insiders

DOCKF Stock  USD 0.11  -0.05  -31.25%   
Beyond Medical employs about 8 people. The company is managed by 8 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. A leadership review of Beyond Medical Technologies matters because management quality often shapes how effectively strategy is translated into revenue growth, margins, and cash generation. That matters because management quality often influences how well a company responds when business conditions become less favorable.

Management Team Effectiveness

The company has return on total asset (ROA) of -20.11 % which means that it generated a loss of $20.11 on every $100 of assets employed. This places it below most industry peers. Similarly, it shows a return on equity (ROE) of -314.01 %, which indicates that equity investment in it has not been earning a positive return.
As of this Saturday, Common Stock Shares Outstanding is anticipated to decline to approximately 6.8 M. In addition to that, Net Loss is anticipated to decline to approximately -2.8 M. Beyond Medical displays a meaningful amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Approximately 0% of Beyond Medical's shares are held by institutions, 35% by insiders, and 65% by the general public.

Holders Distribution

Institutional investors in Beyond Medical Technologies typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. The opportunity for retail investors is not to imitate blindly, but to understand how large-holder positioning may affect liquidity, volatility, and timing.

Market Cap and Value

Workforce Comparison

Beyond Medical Technologies is currently under evaluation in number of employees across its competitive set. The total workforce of Industrials industry is currently estimated at about 6,955. Beyond Medical adds roughly 0.0 in number of employees claiming only tiny portion of equities under Industrials sector.

Benchmark Summation

Notable Stakeholders

Reviewing the stakeholders around Beyond Medical can help investors understand which people or institutions may influence direction, governance, and strategic pressure. Used properly, stakeholder review supports staying aware of the people and incentives that may be shaping key decisions behind the scenes.
Daniel LiuCEO DirectorProfile
Harveer SidhuPresident DirectorProfile
Jatin BakshiCFO SecretaryProfile
Stevenson TyInterim OfficerProfile
Kulwant MalhiChairman CEOProfile
CPA CGAChief OfficerProfile
Karen LauristonCommunity InvestorProfile
Litong CaoChief OfficerProfile

Management Information & Data Sources

Beyond Medical is a micro-cap company in Industrial Machinery & Supplies & Components, Pollution & Treatment Controls, Industrials. Executive review focuses on insiders, senior management, and employee signals. Leadership continuity may improve comparability across reporting periods and business cycles. CEO is Kulwant Malhi with 8 employees and 8 reported executives.

The analytics block for Beyond Medical Technologies relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor
Last reviewed on March 13th, 2026

Workforce Efficiency and Productivity

Workforce efficiency at Beyond Medical Technologies can help investors judge how effectively labor resources are being converted into revenue and profit over time. The stronger interpretation compares these measures with sector norms because labor intensity varies meaningfully across industries.

Beyond Medical Manpower Efficiency

Return on Beyond Medical Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee35.7K
Net Loss Per Executive35.7K

Popular Tools for Beyond Stock analysis

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon